Molecular Medicine is an open access biomedical research journal seeking insight into the cellular and molecular basis of disease. More.

Published by the Feinstein Institute for Medical Research (New York), Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. Click here for more regarding the editorial process.


View Molecular Medicine's Editorial Board.

The 2012 Journal Citation Report® (JCR), showing impact factors calculated from citations of articles published in 2011 and 2010, lists Molecular Medicine with an impact factor of 4.469. JCR category rankings are as follows: Medicine, Research & Experimental 22/121, Cell Biology 57/184, Biochemistry & Molecular Biology 66/290. 

Molecular Medicine publishes work in the format of original research articles, review articles, editorials, commentaries, and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine. Authors click here for more information.

Are you reviewing a manuscript for Molecular Medicine? Click here for a 'how-to' guide. 





Centricity Series are full-day symposia bringing together clinicians and researchers to speak about a specific disease topic.
More.



The Merinoff World Congress 2014: B-1 Cells will feature insightful discussion on the role of B-1 cell biology and new discoveries. More.



The Merinoff Syposia are unique in their developmental methodology, programatic content and desired outcomes. More.



The annual Ross Prize in Molecular Medicine aims to help cultivate promising careers in science and research.
More.



The Anthony Cerami Award in Translational Medicine honors investigators who have created the fundamental innovation necessary for molecular medicine to advance into clinical practice. More.